HOME > 当科における教育・研究 > 業績

当科における教育・研究


2016年

Pre-operative Assessment of Psychological Characteristics and Mood States in Living Donor Kidney and Liver Transplantation.
Kouhei Nishikawa, Tomonori Hasegawa, Akihiro Usami, Aiko Urawa, Saori Watanabe, Shugo Mizuno, Shuji Isaji, Yoshiki Sugimura, Motohiro Okada
Transplantation Proceedings 48(4) : 1018-1021, 2016

Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer.
Takeshi Sasaki, Kenichiro Ishii, Yoichi Iwamoto, Manabu Kato, Manabu Miki, Hideki Kanda, Kiminobu Arima, Taizo Shiraishi, Yoshiki Sugimura
Laboratory investigation 96(3) : 338-349, 2016

Efficacy of ethinylestradiol re-challenge for metastatic castration-resistant prostate cancer.
Takehisa Onishi, Takuji Shibahara, Satoru Masui, Yusuke Sugino, Shinichiro Higashi, Takeshi Sasaki
Anticancer Research 36(6) : 2999-3004, 2016

Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle invasive bladder cancer.
Takehisa Onishi, Yusuke Sugino, Takuji Shibahara, Satoru Masui, Tadashi Yabana, Takeshi Sasaki
BJU international 119(2) : 276–282, 2016

Photoselective vaporization of the prostate: the long-term outcomes and safety during 10 years of follow-up.
Yamada Yasushi, Furusawa Jun, Sugimura Yoshiki, Kuromatsu Isao
Journal of endourology 30(12) : 1306-1311, 2016

The clinical trial on the safety and effectiveness of the photodynamicdiagnosis of non-muscle-invasive bladder cancer using fluorescentlight-guided cystoscopy after oral administration of 5-aminolevulinicacid (5-ALA).
Keiji Inoue, Hideyasu Matsuyama, Kiyohide Fujimoto, Yoshihiko Hirao, Hironobu Watanabe, Seiichiro Ozono, Masafumi Oyama, Munehisa Ueno, Yoshiki Sugimura, Hiroaki Shiina, Hiromitsu Mimata, Haruhito Azuma, Yasushi Nagase, Akio Matsubara, Yoichi M Ito, Taro Shuin
Photodiagnosis and photodynamic therapy 13 : 91-96, 2016

Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer.
Kenichiro Ishii, Yoshiki Sugimura
The Prostate 76(4) : 376-382, 2016

Evaluation of predictors of unfavorable pathological features in men eligible for active surveillance using radical prostatectomy specimens: a multi-institutional study.
Kei Mizuno, Takahiro Inoue, Hidefumi Kinoshita, Toshifumi Yano, Hiroaki Kawanishi, Hideki Kanda, Naoki Terada, Takashi Kobayashi, Tomomi Kamba, Yoshiki Mikami, Taizo Shiraishi, Yoshiko Uemura, Yukihiro Imai, Gen Honjo, Tomoyuki Shirase, Kazuhiro Okumura, Mutsushi Kawakita, Keiji Ogura, Yoshiki Sugimura, Tadashi Matsuda, Osamu Ogawa
Japanese journal of clinical oncology 46 (12) : 1156-1161, 2016

Histone deacetylase inhibition in prostate cancer triggers miR-320-mediated suppression of the androgen receptor.
Shinya Sato, Keisuke Katsushima, Keiko Shinjo, Akira Hatanaka, Fumiharu Ohka, Shugo Suzuki, Aya Naiki-Ito, Norihito Soga, Satoru Takahashi, Yutaka Kondo
Cancer research 76 (14) : 4192-4204, 2016

High-dose radiotherapy with helical tomotherapy and long-term androgen deprivation therapy for prostate cancer: 5-year outcomes.
Natsuo Tomita, Norihito Soga, Yuji Ogura, Norio Hayashi, Takumi Kageyama, Makoto Ito, Yutaro Koide, Maiko Yoshida, Kana Kimura, Chiyoko Makita, Hiroyuki Tachibana, Takeshi Kodaira
Journal of Cancer Research and Clinical Oncology 142(7) : 1609-1619, 2016

Aldehyde dehydrogenase 2 (ALDH2) and alcohol dehydrogenase 1B (ADH1B) polymorphisms exacerbate bladder cancer risk associated with alcohol drinking: gene-environment interaction.
Natsuo Tomita, Norihito Soga, Yuji Ogura, Norio Hayashi, Takumi Kageyama, Makoto Ito, Yutaro Koide, Maiko Yoshida, Kana Kimura, Chiyoko Makita, Hiroyuki Tachibana, Takeshi Kodaira
Carcinogenesis 37(6) : 583-588, 2016

2015年

Pretherapeutic plasma fibrinogen level is an independent survival predictor in renal cell carcinoma.
Takeshi Sasaki, Takehisa Onishi
Oncology research and treatment 38(7-8) : 374-378, 2015

Identification of a new pharmacological activity of the phenylpiperazine derivative naftopidil: tubulin-binding drug.
Kenichiro Ishii, Yoshiki Sugimura
Journal of Chemical Biology 8 (1): 5-9, 2015

Review of bioptic Gleason scores by central pathologist modifies the risk classification in prostate cancer.
Kenichiro Ishii, Yoshiki Sugimura
Journal of Chemical Biology 8(1) : 5-9, 2014

Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates.
Norihito Soga, Yasushi Yatabe, Takumi Kageyama, Yuji Ogura, Norio Hayashi
Urologia International. 95(4) : 452-456, 2015

Clinical effect of switching from a luteinizing hormone releasing hormone agonist to an antagonist in patients with castration-resistant prostate cancer and serum testosterone level ≥20 ng/dl.
Norihito Soga, Takumi Kageyama, Yuji Ogura, Tomomi Yamada, Norio Hayashi
Current Urology 9(1) : 31-35, 2015

CT-Guided Percutaneous Cryoablation in Renal Cell Carcinoma: Factors Affecting Local Tumor Control.
Takashi Yamanaka, Koichiro Yamakado, Tomomi Yamada, Masashi Fujimori, Haruyuki Takaki, Atsuhiro Nakatsuka, Hajime Sakuma, Yoshiki Sugimura
Interventional Oncology 26(8) : 1147-1153, 2015

Unresectable Adrenal Metastases: Clinical Outcomes of Radiofrequency Ablation.
Takaaki Hasegawa, Koichiro Yamakado, Atsuhiro Nakatsuka, Junji Uraki, Takashi Yamanaka, Masashi Fujimori, Manabu Miki, Takeshi Sasaki, Hajime Sakuma, Yoshiki Sugimura
Radiology 277(2) : 584-593, 2015

International prostate symptom score (IPSS) change and changing factor in intensity-modulated radiotherapy combined with androgen deprivation therapy for prostate cancer.
Natsuo Tomita, Isao Oze, Hidetoshi Shimizu, Maiko Yoshida, Kana Kimura, Keiichi Takehana, Arisa Shimizu, Chiyoko Makita, Hiroyuki Tachibana, Takeshi Kodaira, Norihito Soga, Yuji Ogura, Norio Hayashi
Nagoya Journal of Medical Science 77(4) : 637–646, 2015

2014年

The usefulness of diffusion-weighted magnetic resonance imaging in bladder cancer staging and functional analysis.
Yasushi Yamada, Shigeki Kobayashi, Shiho Isoshima, Kiminobu Arima, Hajime Sakuma, Yoshiki Sugimura
Journal of cancer research and therapeutics 10(4) : 878-882, 2014

Usefulness of monitoring cell-mediated immunity for predicting post-kidney transplantation viral infection.
Kouhei Nishikawa, Shugo Mizuno, Satoru Masui, Yasushi Yamada, Kiminobu Arima, Shuji Isaji, Yoshiki sugimura
Transplantation proceedings 46(2) : 552-555, 2014

Identification of a new pharmacological activity of the phenylpiperazine derivative naftopidil: tubulin-binding drug.
Kenichiro Ishii, Yoshiki Sugimura
Journal of Chemical Biology 8(1) : 5-9, 2014

Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates.
Koichiro Yamakado, Akihiko Matsumine, Tomoki Nakamura, Atsuhiro Nakatsuka, Haruyuki Takaki, Takao Matsubara, Kunihiro Asanuma, Akihiro Sudo, Yoshiki Sugimura, Hajime Sakuma
International Journal of Clinical Oncology 19(5) : 955-962, 2014

Radiofrequency Ablation versus Radical Nephrectomy: Clinical Outcomes for Stage T1b Renal Cell Carcinoma.
Haruyuki Takaki, Norihito Soga, Hideki Kanda, Atsuhiro Nakatsuka, Junji Uraki, Masashi Fujimori, Takashi Yamanaka, Takaaki Hasegawa, Kiminobu Arima, Yoshiki Sugimura, Hajime Sakuma, Koichiro Yamakado
Radiology 270(1) : 292-299, 2014

Essential roles of epithelial bone morphogenetic protein signaling during prostatic development.
Akiko Omori, Shinichi Miyagawa, Yukiko Ogino, Masayo Harada, Kenichiro Ishii, Yoshiki Sugimura, Hajime Ogino, Naomi Nakagata, Gen Yamada
Endocrinology 155(7) : 2534-2544, 2014

A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population.
Chikashi Terao, Naoki Terada, Keitaro Matsuo, Takahisa Kawaguchi, Koji Yoshimura, Norio Hayashi, Masakazu Shimizu, Norihito Soga, Meiko Takahashi, Yoshihiko Kotoura, Ryo Yamada, Osamu Ogawa, Fumihiko Matsuda
Journal of Medical Genetics 51(8) : 530-536, 2014

High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients.
Yasuhide Miyoshi, Hiroji Uemura, Susumu Umemoto, Kentaro Sakamaki, Satoshi Morita, Kazuhiro Suzuki, Yasuhiro Shibata, Naoya Masumori, Tomohiko Ichikawa, Atsushi Mizokami, Yoshiki Sugimura, Norio Nonomura, Hideki Sakai, Seijiro Honma, Masaoki Harada, Yoshinobu Kubota
BMC cancer 14 : 717, 2014

A case of IgG4-positive plasma cell-rich tubulointerstitial nephritis in a kidney allograft mimicking IgG4-related kidney disease.
Kouhei Nishikawa, Asami Takeda, Satoru Masui, Hideki Kanda, Yasushi Yamada, Kiminobu Arima, Kunio Morozumi, Yoshiki Sugimura
Nephrology 19(S3) : 52-56, 2014

Successful treatment of non-invasive bladder tumour in a haemophilia A patient with high-responding inhibitors: a case report.
Takeshi Sasaki, Takeshi Matsumoto, Hideo Wada, Kohshi Ohishi, Hideki Kanda, Yasushi Yamada, Kiminobu Arima, Naoyuki Katayama, Yoshiki Sugimura
Haemophilia 20(6) : e399–e401, 2014

2013年

Manserin as a novel histochemical neuroendocrine marker in prostate cancer.
Kouhei Nishikawa, Norihito Soga, Kenichiro Ishii, Manabu Kato, Yoichi Iwamoto, Yasuhide Hori, Michiru Etoh, Takeshi Ohkawara, Tomomi Yamada, Katsunori Uchida, Hideaki Kise, Kiminobu Arima, Masaaki Narita, Taizo Shiraishi, Yoshiki Sugimura
Urologic Oncology 31(6) : 787-795, 2013

Oral naftopidil suppresses human renal-cell carcinoma by inducing G(1) cell-cycle arrest in tumor and vascular endothelial cells.
Yoichi Iwamoto, Kenichiro Ishii, Takeshi Sasaki, Manabu Kato, Hideki Kanda, Yasushi Yamada, Kiminobu Arima, Taizo Shiraishi, Yoshiki Sugimura
Cancer Prevention Research 6(9) : 1000-1006, 2013

Activation of FGF2-FGFR Signaling in the Castrated Mouse Prostate Stimulates the Proliferation of Basal Epithelial Cells.
Manabu Kato, Kenichiro Ishii, Yoichi Iwamoto, Takeshi Sasaki, Hideki Kanda, Yasushi Yamada, Kiminobu Arima, Taizo Shiraishi, Yoshiki Sugimura
Biology of Reproduction 89(4) : 81, 2013

Limited expression of cancer-testis antigens in renal cell carcinoma patients.
Norihito Soga, Yasuhide Hori, Koichiro Yamakado, Hiroaki Ikeda, Naoko Imai, Shinichi Kageyama, Kazunori Nakase, Atsushi Yuta, Norio Hayashi, Hiroshi Shiku, Yoshiki Sugimura
Molecular and Clinical Oncology 1(2) : 326-330, 2013

Renal cell carcinoma: radiofrequency ablation with a multiple-electrode switching system--a phase II clinical study.
Haruyuki Takaki, Atsuhiro Nakatsuka, Junji Uraki, Takashi Yamanaka, Masashi Fujimori, Takaaki Hasegawa, Kiminobu Arima, Yoshiki Sugimura, Koichiro Yamakado
Radiology 267(1) : 285-292, 2013

Immune Response following Liver Transplantation Compared to Kidney Transplantation: Usefulness of Monitoring Peripheral Blood CD4+ Adenosine Triphosphate Activity and Cytochrome P450 3A5 Genotype Assay.
Yu Nobuoka, Shugo Mizuno, Kouhei Nishikawa, Kaname Nakatani, Yuichi Muraki, Tomomi Yamada, Masahiro Okuda, Tsutomu Nobori, Yoshiki Sugimura, Shuji Isaji
Clinical and Developmental Immunology 2013 : Article ID 936063, 8 pages, 2013

Preliminary analysis of risk factors for late rectal toxicity after helical tomotherapy for prostate cancer.
Natsuo Tomita, Norihito Soga, Yuji Ogura, Norio Hayashi, Hidetoshi Shimizu, Takashi Kubota, Junji Ito, Kimiko Hirata, Yukihiko Ohshima, Hiroyuki Tachibana, Takeshi Kodaira
Journal of Radiation Research 54(5) : 919–924, 2013

The incidence of benign lesions in partial or radical resected suspicious renal masses determined by helical enhanced computed tomography imaging.
Norihito Soga Yuji Ogura Norio Hayashi
Current Urology 7 : 70-73, 2013

2012年

Characterization of the low pH/low nutrient-resistant LNCaP cell subline LNCaP-F10.
Kazuhiro Iguchi, Yuri Hayakawa, Kenichiro Ishii, Kaoru Matsumoto, Shigeyuki Usui, Yoshiki Sugimura, Kazuyuki Hirano
Oncology reports 28(6) : 2009-2015, 2012

Low incidence of benign lesions in resected suspicious renal masses greater than 2 cm: Single-center experience from Japan
Norihito Soga, Kouhei Nishikawa, Haruyuki Takaki, Yasushi Yamada, Kiminobu Arima, Norio Hayashi, Yoshiki Sugimura
International journal of urology 19(8) : 729-734, 2012

Low androgen sensitivity is associated with low levels of Akt phosphorylation in LNCaP-E9 cells
Kazuhiro Iguchi, Kazuhiro Fukami, Kenichiro Ishii, Takashi Otsuka, Shigeyuki Usui, Yoshiki Sugimura, Kazuyuki Hirano
Journal of andrology 33(4) : 660-666, 2012

The long-term results with delayed-combined androgen blockade therapy in local or locally advanced prostate cancer.
Norihito Soga, Yasuhide Hori, Yuji Ogura, Norio Hayashi, Yoshiki Sugimura
Japanese journal of clinical oncology 42(6) : 534-540, 2012

Preliminary results of intensity-modulated radiation therapy with helical tomotherapy for prostate cancer.
Natsuo Tomita, Norihito Soga, Yuji Ogura, Norio Hayashi, Hidetoshi Shimizu, Takashi Kubota, Junji Ito, Kimiko Hirata, Yukihiko Ohshima, Hiroyuki Tachibana, Takeshi Kodaira
Journal of cancer research and clinical oncology 138(11) : 1931-1936, 2012

Intermittent Chemotherapy Is a Treatment Choice for Advanced Urothelial Cancer
Takehisa Onishi, Takeshi Sasaki, Akira Hoshina
Oncology 83 : 50-56, 2012

Cut off value of time to prostate specific antigen nadir is inversely correlated with disease progression in advanced prostate cancer
Takeshi Sasaki, Takehisa Onishi, Akira Hoshina
Endocrine-related cancer 19 : 725-730, 2012

2011年

Naftopidil, a subtype selective alpha1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma.
Yasuhide Hori, Kenichiro Ishii, Hideki Kanda, Yoichi Iwamoto, Kohei Nishikawa, Norihito Soga, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
Cancer Prevention Research 4(1) : 87-96, 2011

Endocrine disrupter bisphenol A increases in situ estrogen production in mouse urogenital sinus.
Shigeki Arase, Kenichiro Ishii, Katsuhide Igarashi, Kenichi Aisaki, Yuko Yoshio, Ayami Matsushima, Yasuyuki Shimohigashi, Kiminobu Arima, Jun Kanno, Yoshiki Sugimura
Biology of Reproduction 84(4) : 734-742, 2011

Management of renal tumors in Von Hippel-Lindau disease by percutaneous CT fluoroscopic guided radiofrequency ablation: preliminary results
Yoichi Iwamoto, Hideki Kanda, Koichiro Yamakado, Norihito Soga, Kiminobu Arima, Yoshiki Sugimura
Familial Cancer 10(3) : 529-534, 2011

Manserin as a novel histochemical neuroendocrine marker in prostate cancer.
Kouhei Nishikawa, Norihito Soga, Kenichiro Ishii, Manabu Kato, Yoichi Iwamoto, Yasuhide Hori, Michiru Etoh, Takeshi Ohkawara, Tomomi Yamada, Katsunori Uchida, Hideaki Kise, Kiminobu Arima, Masaaki Narita, Taizo Shiraishi, Yoshiki Sugimura
Urologic oncology : 2011 (in press)

Heterogenous induction of carcinoma-associated fibroblast-like differentiation in normal human prostatic fibroblasts by co-culturing with prostate cancer cells.
Kenichiro Ishii, Atsushi Mizokami, Toshiyuki Tsunoda, Kazuhiro Iguchi, Manabu Kato, Yasuhide Hori, Kiminobu Arima, Mikio Namiki, Yoshiki Sugimura
Journal of Cellular Biochemistry 112 : 3604-611, 2011

Androgen receptor W741C and T877A mutations in AIDL cells, an androgen-independent subline of prostate cancer LNCaP cells.
Takashi Otsuka, Kazuhiro Iguchi, Kazuhiro Fukami, Kenichiro Ishii, Shigeyuki Usui, Yoshiki Sugimura, Kazuyuki Hirano
Tumour biology 32(6) : 1097-1102, 2011

Castration- and Aging-Induced Changes in the Expression of Zinc Transporter and Metallothionein in Rat Prostate
Kazuhiro Iguchi, Naoaki Morihara, Shigeyuki Usui, Minoru Hayama, Yoshiki Sugimura, Kazuyuki Hirano
Journal of Andrology 32(2) : 144-150, 2011

Epithelial Bmp (Bone morphogenetic protein) signaling for bulbourethral gland development: a mouse model for congenital cystic dilation.
Akiko Omori, Masayo Harada, Sho Ohta, Mylah Villacorte, Yoshiki Sugimura, Taizou Shiraishi, Kentaro Suzuki, Naomi Nakagata, Takaaki Ito, Gen Yamada
Congenital Anomalies 51(3) : 102-109, 2011

Low Androgen Sensitivity Is Associated with Low Levels of Akt Phosphorylation in LNCaP-E9 Cells.
Kazuhiro Iguchi, Kazuhiro Fukami, Kenichiro Ishii, Takashi Otsuka, Shigeyuki Usui, Yoshiki Sugimura, Kazuyuki Hirano
Journal of Andrology 33(4) : 660-666, 2011

The impact of body mass index and subcutaneous fat volume on the need for extended incision during minimum incision endoscopic surgery for radical nephrectomy
Norihito Soga, Yasushi Yamada, Yoshihiro Hasegawa, Haruyuki Takaki, Naoki Nagasawa, Hideaki Kise, KIminobu Arima, Yoshiki Sugimura
The Nishinihon journal of urology 73(12) : 647-53, 2011

Combination chemotherapy comprising docetaxel and zoledronic acid plus dexamethazone for hormone-refractory prostate cancer patients.
Yasushi Yamada, Norihito Soga, Manabu Miki, Satoru Masui, Yuko Yoshio, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
The Nishinihon journal of urology 73(11) : 605-610, 2011

The impact of the pre-operative serum albumin level and post-operative C-reactive protein nadir for the survival in the non-metastatic renal cell carcinoma with vessel thrombus after nephrectomy
Norihito Soga, Kouehi Nishikawa, Yasushi Yammada, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
Current urology 5 : 190-195, 2011

Continuous saline bladder irrigation after transurethral resection is a prophylactic treatment choice for non-muscle invasive bladder tumor.
Takehisa Onishi, Takeshi Sasaki, Akira Hoshina, Tadashi Yabana
Anticancer research 31(4) : 1471-4, 2011

Nadir PSA level and time to PSA nadir following primary androgen deprivation therapy are the early survival predictors for prostate cancer patients with bone metastasis.
Takeshi Sasaki, Takehisa Onishi, Akira Hoshina
Prostate cancer and prostatic diseases 14(3) : 248-252, 2011

2010年

Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer.
Norihito Soga, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
The International Journal of Clinical Oncology 15 : 376-381, 2010

Structural changes in alpha1-adrenoceptor antagonist-treated human prostatic stroma.
Tetsuya Imamura, Kenichiro Ishii, Hideki Kanda, Shigeki Arase, Yuko Yoshio, Yasuhide Hori, Norihito Soga, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
Clinical and experimental medicine 10(2) : 99-106, 2010

Effect of transforming growth factor α overexpression on urogenital organ development in mouse.
Yuko Yoshio, Kenichiro Ishii, Shigeki Arase, Yasuhide Hori, Kohei Nishikawa, Norihito Soga, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
Differentiation 80(2-3) : 82-88, 2010

Risk Factors Contributing to the Development of Hypocalcemia after Zoledronic Acid Administration in Patients with Bone Metastases of Solid Tumor.
Miho Hanamura, Takuya Iwamoto, Norihito Soga, Yoshiki Sugimura, Masahiro Okuda
Biological & Pharmaceutical Bulletin 33(4) : 721-724, 2010

Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma.
Haruyuki Takaki, Koichiro Yamakado, Shigeki Kobayashi, Atsuhiro Nakatsuka, Junji Uraki, Masataka Kashima, Norihito Soga, Kiminobu Arima, Kan Takeda, Yoshiki Sugimura
Japanese Journal of Radiology 28 : 460-468, 2010

Endodermal origin of bladder trigone inferred from mesenchymal-epithelial interaction.
Stacy T Tanaka, Kenichiro Ishii, Romano T Demarco, John C Pope, John W Brock, Simon W Hayward
The Journal of Urology 183(1) : 386-391, 2010

2009年

Complications of Radiofrequency Ablation and Cryoablation for small RCC.
Kiminobu Arima, Kouichirou Yamakado, Norihito Soga, Hideaki Kise, Kan Takeda, Yoshiki Sugimura
Recent Advances in Endourology 11 : 131-136, 2009

Gemcitabine / Capecitabine therapy as a second-line treatment for advanced immunotherapy resistant renal cell cancer in Japanese cases.
Norihito Soga, Yasushi,Yamada Kouhei Nishikawa, Yoshihiro Hasegawa, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urology 16(6) : 576-9, 2009

Intermittent docetaxel with estramustine in hormone refractory prostate cancer in Japanese cases.
Norihito Soga, Manabu Katou, Yoshihiro Hasegawa, Kouhei Nishikawa, Yasushi Yamada, Hideaki Kise, Kiminobu Arima,Sugimura Yoshiki
International Journal of Clinical Oncology 14(2) : 130-5, 2009

Evidence that androgen-independent stromal growth factor signals promote androgen-insensitive prostate cancer cell growth in vivo.
Ishii Kenichiro, Imamura Tetsuya, Iguchi Kazuhiro, Arase Sshigeki, Yoshio Yuko, Arima Kiminobu, Hirano Kazuyuki, Sugimura Yoshiki
Endocrine Related Cancer 16(2) : 415-428, 2009

Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma.
Norihito Soga, Koichiro Yamakado, Hideo Gohara, Haruyuki Takaki, Takao Hiraki, Tomomi Yamada, Kiminobu Arima, Kan Takeda, Susumu Kanazawa, Yoshiki Sugimura
British Journal of Urology International 104(6):790-794, 2009

Adult urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-s signaling.
Li X, Wang Y, Sharif-Afshar AR, Uwamariya C, Yi A, Kenichiro Ishii, Hayward SW, Matusik RJ, Bhowmick NA.
Differentiation 77:95-102, 2009

2008年

Adjuvant M-VAC (methotrexate, vinblastine,adriamycin and cisplatin) chemotherapy prevent recurrent of bladder tumors after operation in upper urinary tract transitional cell carcinoma.
Norihito Soga, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urology 15(9) : 800-803, 2008

Comparison of radical nephrectomy under the minimal incision with portless endscopic surgery (PLES) versus transperitonial laparoscopic surgery.
Norihito Soga, Manabu Kato, Yoshihiro Hasegawa, Kouhei Nishikawa, Yasushi Yamada, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urology 15 : 1018-1021, 2008

Undetectable level of prostate specific antigen (PSA) nadir predicts PSA biochemical failure in local prostate cancer with delayed-combined androgen blockade.
Norihito Soga, Kiminobu Arima, Yoshiki Sugimura
Japanese Journal of Clinical Oncology  38 : 617-622, 2008

Role of stromal tenascin-C in mouse prostatic development and epithelial cell differentiation.
Kenichiro Ishii, Kyoko Imanaka-Yoshida, Toshimichi Yoshida, Yoshiki Sugimura
Developmental Biology 324 : 310-319, 2008

Improvement to predict tumorigenic phenotype of androgen-insensitive human LNCaP prostatic cancer cell subline in recombination with rat urogenital sinus mesenchyme.
Masahiro Kanai, Kenichiro Ishii, Hideki Kanda , Yuji Ogura, Hideaki Kise, Kiminobu Arima, Yoshiki Sugimura
Cancer Science 99(12) : 2435-2443, 2008

Naftopidil, a selective a-1 adrenoreptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest.
Hideki Kanda, Kenichiro Ishii, Yuji Ogura, Tetsuya Imamura, Masahiro Kanai, Kiminobu Arima, Yoshiki Sugimura
International Journal of Cancer 122 : 444-451, 2008

Photoselective vaporization of the prostate using high power (80 W) KTP laser
: one year follow up of the first 101 patients in Japan.
Yasuhide Hori, Isao Kuromatsu, Yoshiki Sugimura
International Journal of Urology 15(12) : 1067-1071, 2008

Lack of involvement of the GNAS1 T393C polymorphism in prostate cancer risk in a Japanese population.
Masatoshi Watanabe, Yoshifumi Hirokawa, Mayumi Tsuji, Masato Yanagawa, Tetsuya Murata, Hiroyoshi Suzuki, Tomohiko Ichikawa, Takahiko Katoh, Yohsiki Sugimura, Taizo Shiraishi
Anticancer Research 28(6A) : 3711-3716, 2008

2007年

Image-guided radiofrequency ablation for adrenocortical adenoma with Cushing syndrome:Outcomes after mean follow-up of 33 months.
Kiminobu Arima, Kouichirou Yamakado, Ryuichi Suzuki, Hiroshi Matsuura, Atsuhiro Nakatsuka, Kan Takeda, Yoshiki Sugimura
Urology 70 : 407-411, 2007

Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: Results at 2-year mean follow-up.
Kiminobu Arima, Kouichirou Yamakado,Hiroyuki Kinbara, Atsuhiro Nakatsuka, Kan Takeda, Yoshiki Sugimura
International Journal of Urology 14 : 585-590, 2007

Bisphenol A induces permanent squamous change in mouse prostatic epithelium
Yuji Ogura, Kenichiro Ishii, Hideki Kanda, Masahiro Kanai, Kiminobu Arima, Wang YZ, Yoshiki Sugimura
Differentiation 75 : 745-756, 2007

Proprotein convertases modulate budding and branching morphogenesis of rat ventral prostate.
Katsunori Uchida, Masahiro Kanai, Shigenori Yonemura, Kenichiro Ishii, Yoshifumi Hirokawa, Yoshiki Sugimura
International Journal of Developmental Biology 51 : 229-233, 2007

Prostate-specific antigen half-life and pretreatment prostate-specific antigen :Crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy.
Norihito Soga, Takehisa Onishi, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urology 14(3) : 192-197, 2007

Paclitaxel Carboplatin chemotherapy as a second-line chemotherapy for advanced platinum resistant urothelial cancer in Japanese cases.
Norihito Soga, Takehisa Onishi, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urology 14(9) : 828-832, 2007

Isolation and Characterization of LNCaP Sublines Differing in Hormone Sensitivity.
Kazuhiro Iguchi, Kenichiro Ishii, Nakano Toru, Takashi Otsuka, Shigeyuki Usui, Yoshiki Sugimura, Kazuyuki Hirano
Journal of Andrology 28(5) : 670-678, 2007

Assesment of Health-related Quolity of Life after Radiofrequency Ablation or Laparoscopic Surgery for Small Renal CellCarcinoma : a Prospective Study with Medical Outcomes Study 36-Item Health Survey(SF-36).
Takehisa Onishi, Kouhei Nishikawa, Yoshihiro Hasegawa, Yasushi Yamada, Norihito Soga, Kiminobu Arima, Kouichiro Yamakado, Akira Hoshina ,Yoshiki Sugimura
Japanese Journal of Clinical Oncology 37 : 750-4, 2007

Global update on defining and treating high-risk localized prostate cancer with leuprorelin : an Asian perspective.
Atsushi Mizokami, Satoshi Ueno, Takashi Fukagai, Kazuto Ito, Hidetoshi Ehara, Hiroyuki Kinbara, Hideki Origasa, Michiyuki Usami, Mikio Namiki, Hideyuki Akaza
Britishi Journal of Urology International 99 Suppl 1 : 6-9, discussion 17-8, 2007

Early tumor regression following severe lung injury after allogeneic stem cell transplantation in a patient with renal cell carcinoma.
Natsuki Hoshino, Kazunori Nakase, Isao Tawara, Shinichi Kageyama, Kohshi Ohishi, Yoshiki Sugimura, Hiroshi Shiku, Noriyuki Katayama
Internal Medicine 46(6) : 291-3, 2007

Intracellular localization of protein C inhibitor(PCI) and urinary plasminogen activator in renal tubular epithelial cells from humans and human PCI gene transgenic mice.
Zhenhu Song, Ning Ma, Tatsuya Hayashi, Esteban C.Gabazza, Yoshiki Sugimura, Koji Suzuki
Histochemistry and Cell Biology 128 : 293-300, 2007

2006年

Ureteral obstruction associated with pelvic inflammatory disease in a long-term intrauterine contraceptive device user.
Shigenori Yonemura, Mitsuhiko Moriya, Yasuhide Hori, Kiminobu Arima, Nagayasu Toyoda, Yoshiki Sugimura
International Journal of Urology 13(3) : 315-7, 2006

Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm : initial experience.
Kouichiro Yamakado, Atsuhiro Nakatsuka, Shigeki Kobayashi, Masao Akeboshi, Haruyuki Takagi, Zentaro Kariya, Hiroyuki Kinbara, Kiminobu Arima, Makoto Yanagawa, Yasuhide Hori , Hiromi Kato, Yoshiki Sugimura, Kan Takeda
Cardiovascular and Interventional Radiolgy 29(3) : 389-94, 2006

Steroid hormones stimulate human prostate cancer progression and metastasis.
Ricke WA, Kenichiro Ishii, Ricke EA, Simko J, Wang Y, Hayward SW, Cunha GR
International Journal of Cancer 118(9) : 2123-31, 2006

Androgen dependent prostate epithelial cell selection by targeting ARR2PBneo to the mouse prostate Lab Invest.
Wang Y, Kasper S, Yuan J, Jin RJ, Zhang J, Kenichiro Ishii, Wills ML, Hayward SW, Matusik RJ
Laboratory Investigation 86(10) : 1074-88, 2006

2005年

Treatment option for pT3 patient after radical prostatectomy.
Yoshiki Sugimura, Toshiaki Wakita, Atsushi Mizogami
Hinyokika Kiyo 51(9) : 571-3, 2005

Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells.
Takuji Shibahara, Takehisa Onishi, Franco OE, Kiminobu Arima, Yoshiki Sugimura
Anticancer Research 25(3B) : 1881-8, 2005

Natural history of human prostate gland : Morphometric and histopathological analysis of Japanese men.
Shinji Fujikawa, Hiroshi Matsuura, Masahiro Kanai, Miki Fumino, Kenichiro Ishii, Kiminobu Arima, Taizo Shiraishi, Yoshiki Sugimura
Prostate 65(4) : 355-64, 2005

Successful management of inferior vena cava thrombus complicating advanced germ cell testicular tumor with temporary inferior vena cava filter.
Satoru Masui, Takehisa Onishi, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urology 12(5) : 513-5, 2005

Papillary adenocarcinoma of the renal pelvis and ureter producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125.
Takehisa Onishi, Franco OE, Takuji Shibahara, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urolgy 12(2) : 214-6, 2005

Use of tissue recombination to predict phenotypes of transgenic mouse models of prostate carcinoma.
Kenichiro Ishii, Shappell SB, Matusik RJ, Hayward SW
Laboratory Investigation 85(9) : 1086-103, 2005

Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation.
Gao N, Kenichiro Ishii, Mirosevich J, Kuwajima S, Oppenheimer SR, Roberts RL, Jiang M, Yu X, Shappell SB, Caprioli RM, Stoffel M, Hayward SW, Matusik RJ
Development 132(15) : 3431-43, 2005

Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
Williams K, Fernandez S, Stien X, Kenichiro Ishii, Love HD, Lau YF, Roberts RL, Hayward SW
Prostate 63(4) : 369-84, 2005

2004年

Zinc and Metallothionein Levels and Expression of Zinc Transporters in Androgen-Independent Subline of LNCaP Cells.
Kazuhiro Iguchi, Takashi Otsuka, Shigeyuki Usui, Kenichiro Ishii, Takehisa Onishi, Yoshiki Sugimura, Kazuyuki Hirano
Journal of Andology 25(1) : 154-161, 2004

Evidence that the prostate-specific antigen(PSA)/Zn2+ axis may play a role in human prostate cancer cell invasion.
Kenichiro Ishii, Takashi Otsuka, Kazuhiro Iguchi, Shigeyuki Usui,Hajime Yamamoto, Yoshiki Sugimura, Kazuhiro Yoshikawa, Simon W.Hayward, Kazuyuki Hirano
Cancer Letters 15 207(1) : 79-87, 2004

Radical Cystectomy for Invasive Bladder Cancer : Results of Multi-institutional Pooled Analysis.
Atsushi Takahashi, Taiji Tsukamoto, Ken-ichi Tobisu, Nobuo Shinohara, Kazunari Sato, Yoshihiko Tomita, Shu-ichi Komatsubara, Osamu Nishizawa, Tatsuo Igarashi, Hiroyuki Fujimoto, Hayakazu Nakazawa, Hideki Komatsu, Yoshiki Sugimura, Yoshinari Onomasa.
Japanese Clinical Oncology 34(1) : 14-19, 2004

Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma.
Jing-Shi SU, Kiminobu Arima, Mariko Hasegawa, O.E.Franco, Yoshiki Umeda, Makoto Yanagawa, Yoshiki Sugimura, Juichi Kawamura
International Journal of Urology 11(2) : 74-82, 2004

Identification of differentially methylated CpG islands in prostate cancer.
Yasushi Yamada, Minoru Toyota, Yoshifumi Hirokawa, Hiroyoshi Suzuki, Akimitsu Takagi, Takeshi Matsuzaki, Yoshiki Sugimura, Ryuichi Yatani, Taizo Shiraishi, Masatosi Watanabe
International Journal of Cancer 10 112(5) : 840-5, 2004

Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population.
Takahide Fukatsu, Yoshifumi Hirokawa, Tomio Araki, Takuichi Hioki, Murata T, Hiroyoshi Suzuki, Tomohiko Ichikawa, Hiromasa Tsukino, Qiu D, Takahiro Katoh, Yoshiki Sugimura, Ryuichi Yatani, Taizo Shiraishi, Masatoshi Watanabe
Anticancer Research 24(4) : 2431-7, 2004

Radiofrequency ablation combined with selective renal arterial embolization of small renal cell carcinoma : Early experience.
Kiminobu Arima, Hiroyuki Kinbara, Kouichurou Yamakado, Atsuhiro Nakatsuka, Kan Takeda, Hiromi Kato, Yoshiki Sugimura
Journal of Urology 171(4) : 342-343, 2004

Radiofrequency ablation combined with selective renal arterial embolization of renal cell carcinoma.
Kiminobu Arima, Hiroyuki Kinbara, Kouichiro Yamakado, Asuhiro Nakatsuka, Kan Takeda, Hiromi Kato, Yoshiki Sugimura
British Journal of Urology International 94(2) : 283, 2004

Comparison of cyclosporine concentrations in renal transplant recipients using ACMIA and mFPIA methods.
Yoshiki Kagawa, Makoto Yanagawa, Youichi Muraki, Takuya Iwamoto, Hideki Mizutani, Yoshiki Sugimura, Michio Kojima
Clinical Biochemistry 37 : 1016-1021, 2004

Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis.
Atsushi Takahashi, Taiji Tsukamoto, Kenichi Tobisu, Nobuo Shinohara, Kazunari Sato, Yoshihiko Tomita, Shuichi Komatsubara , Osamu Nishizawa, Tatsuo Igarashi, Hiroyuki Fujimoto, Hayakazu Nakazawa, Hideki Komatsu, Yoshiki Sugimura, Yoshinari Ono, Masao Kuroda, Osamu Ogawa, Yoshihiko Hirao, Tadashi Hayashi, Tomoyasu Tsushima, Yoshiyuki Kakehi, Yoichi Arai, Shouichi Ueda, Masayuki Nakagawa
Japanese Journal of Clinical Oncology 34(1) : 14-9, 2004

Renal lymphoma associated with Castleman's disease.
Takehisa Onishi, Shigenori Yonemura, Yuko Sakata, Yoshiki Sugimura
Scandinavian Journal of Urology and Nephrology 38(1) : 90-91, 2004

Coexistence of renal replacement lipomatosis with xanthogranulomatous pyelonephritis.
Yuko Sakata, Nobutaka Kinoshita, Hiromi Kato, Yasushi Yamada, Yoshiki Sugimura
International Journal of Urology 11(1) : 44-46, 2004

Tuberculid of the penis with a scab on the nodule.
Shigenori Yonemura, Shinji Fujikawa, Su JS, Takehisa Onishi, Kiminobu Arima, Yoshiki Sugimura
International Journal of Urology 11(10) : 931-933, 2004

NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
Jin RJ, Wang Y, Naoya Masumori, Kenichiro Ishii, Taiji Tsukamoto, Shappell SB, Hayward SW, Kasper S, Matusik RJ.
Cancer Research 64(15) : 5489-95, 2004

2003年

Proprotein convertases regulate activity of prostate epithelial cell differentiation markers and are modulated in human prostate cancer cells.
Katsunori Uchida, Chaudhary LR, Yoshiki Sugimura, Adkisson HD, Hruska KA
Journal of Cellular Biochemistry 88 : 394-399, 2003

Phenylacetate Inhibits Growth and Modulates Cell Cycle Gene Expression in Renal Cancer Cell Lines.
Omar E.Franco, Takehisa Onishi, Yoshiki Umeda, Norihito Soga, Toshiaki Wakita, Kiminobu Arima, Makoto Yanagawa, Yoshiki Sugimura
Anticancer Research 23 : 1637-1642, 2003

Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers.
Satoru Takahashi, Shugo Suzuki, Shingo Inaguma, Yoshihisa Ikeda, Cho YM, Norio Hayashi, Takahiro Inoue, Yoshiki Sugimura, Naoki Nishiyama, Tamio Fujita, Chao J, Toshikazu Ushijima, Tomoyuki Shirai
The Prostate 54 : 187-193, 2003

Mitogen-activated protein kinase pathway is involved in androgen-independent PSA gene expression in LNCaP cells.
Franco OE, Takehisa Onishi, Kensuke Yamakawa, Kiminobu Arima, Makoto Yanagawa, Yoshiki Sugimura, Jyuichi Kawamura
The Prostate 56(4) : 319-325, 2003

Proliferative status is a risk index for recurrence in primary superficial(pTa/T1) low-grade urothelial bladder carcinoma.
Jing-Shi Su, Kiminobu Arima, Mariko Hasegawa, O.E.Franco, Makoto Yanagawa, Yoshiki Sugimura, Juichi Kawamura
Acta Urologica Japonica 49 : 649-658, 2003

Pheochromocytoma of the urinary bladder without typical symptoms.
Takehisa Onishi, Yuko Sakata, Shigenori Yonemura, Yoshiki Sugimura
International Journal of Urology 10(7) : 398-400, 2003

2002年

Down-regulation of human X-box binding protein 1 (hXBP-1) expression correlates with tumor progression in human prostate cancers.
Satoru Takahashi, Shugo Suzuki, Shingo Inaguma, Yoshihisa Ikeda, Y-M Cho, Naoki Nishiyama, Tamio Fujita, Takahiro Inoue, Takuichi Hioki, Yoshiki Sugimura, Toshikazu Ushijima, Tomoyuki Shirai
The Prostate 50 : 154-161, 2003

Down-regulation of Lsm1 is involved in human prostate cancer progression
Satoru Takahashi, Sshugo Suzuki, Shingo Inaguma, Y-M Cho, Yoshihisa Ikeda, Norio Hayashi, Takahiro Inoue, Yoshiki Sugimura, Naoki Nishiyama, Tamio Fujita, Toshikazu Ushijima, Tomoyuki Shirai
British Journal of Cancer 86 : 940-946, 2003

Preoperative predictors of cancerous involvement of the neurovascular bundles in patients with localized prostate cancer.
Takahiro Inoue, Takuichi Hioki, Norio Hayashi, Satoru Takahashi, Tomoyuki Shirai, Yoshiki Sugimura
International Journal of Urology 9 : 47-53, 2003

Ureteroarterial fistula controlled by intraluminal ureteral occlusion.
Takahiro Inoue, Takuichi Hioki, Yoichi Arai , Yoshitaka Inaba, Yoshiki Sugimura
International Journal of Urology 9 : 120-121, 2003

NAD(P)H : quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
Nobuyuki Hamajima, Keitaro Matsuo,Hiroji Iwata, Masayuki Shinoda, Yoshitaka Yamamura, Tomoyuki Kato, Shunzo Hatooka, Tetsuya Mitsudomi, Motokazu Suyama, Yoshitoyo Kagami, Michinori Ogura, Manabu Ando, Yoshiki Sugimura, Kazuo Tajima
International Journal of Clinical Oncology 7 : 103-108, 2002

High-Level Expression of Zinc Transporter-2 in the Rat Lateral and Dorsal Prostate.
Kazuhiro Iguchi, Shigeyuki Usui, Takahiro Inoue, Yoshiki Sugimura, Masae Tatematsu, Kazuyuki Hirano
Journal of Andorology 23 : 819-824, 2002

Ureteroarterial fistula controlled by intraluminal ureteral occlusion : a case report.
Takahiro Inoue, Takuichi Hioki, Yoichi Arai, Yoshitaka Inaba, Yoshiki Sugimura
International Journal of Urology 9 : 120-121, 2002

2001年

Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion.
Kenichiro Ishii, Shigeyuki Usui, Yoshiki Sugimura, Sei Yoshida, Takuichi Hioki, Masae Tatematsu, Hajime Yamamoto, Kazuyuki Hirano
International Journal of Cancer 92 : 49-54, 2001

An anterior urethral stitch improves urinary incontinence following radical prostatectomy.
Yoshiki Sugimura, Takuichi Hioki, Yasushi Yamada, Miki Fumino, Takahiro Inoue
International Journal of Urology 8 : 153-157, 2001

Decreases of metallothionein and aminopeptidase N in renal cancer tissues.
Kenichiro Ishii, Shigeyuki Usui, Hajime Yamamoto, Yoshiki Sugimura, Masae Tatematsu, Kazuyuki Hirano
Journal of Biochemistry 129 : 253-258, 2001

Extract from Serenoa repens suppresses the invasion activity of human urological cancer cells by inhibiting urokinase-type plasminogen activator.
Kenichiro Ishii, Shigeyuki Usui, Yoshiki Sugimura, Hajime Yamamoto, Kazuhiro Yoshikawa, Kazuyuki Hirano
Biological & Pharmaceutical Bulletin 24 : 188-190, 2001

Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells.
Kenichiro Ishii, Shigeyuki Usui, Yoshiki Sugimura, Hajime Yamamoto, Kazuhiro Yoshikawa, Kazuyuki Hirano
Biological & Pharmaceutical Bulletin 24 : 226-230, 2001

Real time reverse transcriptase polymerase chain reaction of urinary cytokeratin 20 detects transitional cell carcinoma cells.
Takahiro Inoue, Hayao Nakanishi, Kenichi Inada, Takuichi Hioki, Masae Tatematsu, Yoshiki Sugimura
Journal of Urology 166 : 2134-2141, 2001

ページトップへ戻る